Correlation Between DiaMedica Therapeutics and Tarsus Pharmaceuticals
Can any of the company-specific risk be diversified away by investing in both DiaMedica Therapeutics and Tarsus Pharmaceuticals at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining DiaMedica Therapeutics and Tarsus Pharmaceuticals into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between DiaMedica Therapeutics and Tarsus Pharmaceuticals, you can compare the effects of market volatilities on DiaMedica Therapeutics and Tarsus Pharmaceuticals and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in DiaMedica Therapeutics with a short position of Tarsus Pharmaceuticals. Check out your portfolio center. Please also check ongoing floating volatility patterns of DiaMedica Therapeutics and Tarsus Pharmaceuticals.
Diversification Opportunities for DiaMedica Therapeutics and Tarsus Pharmaceuticals
0.48 | Correlation Coefficient |
Very weak diversification
The 3 months correlation between DiaMedica and Tarsus is 0.48. Overlapping area represents the amount of risk that can be diversified away by holding DiaMedica Therapeutics and Tarsus Pharmaceuticals in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Tarsus Pharmaceuticals and DiaMedica Therapeutics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on DiaMedica Therapeutics are associated (or correlated) with Tarsus Pharmaceuticals. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Tarsus Pharmaceuticals has no effect on the direction of DiaMedica Therapeutics i.e., DiaMedica Therapeutics and Tarsus Pharmaceuticals go up and down completely randomly.
Pair Corralation between DiaMedica Therapeutics and Tarsus Pharmaceuticals
Given the investment horizon of 90 days DiaMedica Therapeutics is expected to generate 1.17 times more return on investment than Tarsus Pharmaceuticals. However, DiaMedica Therapeutics is 1.17 times more volatile than Tarsus Pharmaceuticals. It trades about 0.08 of its potential returns per unit of risk. Tarsus Pharmaceuticals is currently generating about 0.08 per unit of risk. If you would invest 144.00 in DiaMedica Therapeutics on September 3, 2024 and sell it today you would earn a total of 422.00 from holding DiaMedica Therapeutics or generate 293.06% return on investment over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Together |
| Strength | Weak |
| Accuracy | 100.0% |
| Values | Daily Returns |
DiaMedica Therapeutics vs. Tarsus Pharmaceuticals
Performance |
| Timeline |
| DiaMedica Therapeutics |
| Tarsus Pharmaceuticals |
DiaMedica Therapeutics and Tarsus Pharmaceuticals Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with DiaMedica Therapeutics and Tarsus Pharmaceuticals
The main advantage of trading using opposite DiaMedica Therapeutics and Tarsus Pharmaceuticals positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if DiaMedica Therapeutics position performs unexpectedly, Tarsus Pharmaceuticals can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Tarsus Pharmaceuticals will offset losses from the drop in Tarsus Pharmaceuticals' long position.| DiaMedica Therapeutics vs. Milestone Pharmaceuticals | DiaMedica Therapeutics vs. Seres Therapeutics | DiaMedica Therapeutics vs. Inhibikase Therapeutics | DiaMedica Therapeutics vs. Oncolytics Biotech |
| Tarsus Pharmaceuticals vs. DiaMedica Therapeutics | Tarsus Pharmaceuticals vs. Lyra Therapeutics | Tarsus Pharmaceuticals vs. Centessa Pharmaceuticals PLC |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Equity Valuation module to check real value of public entities based on technical and fundamental data.
Other Complementary Tools
| Portfolio Holdings Check your current holdings and cash postion to detemine if your portfolio needs rebalancing | |
| Analyst Advice Analyst recommendations and target price estimates broken down by several categories | |
| Instant Ratings Determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| Portfolio Manager State of the art Portfolio Manager to monitor and improve performance of your invested capital | |
| Positions Ratings Determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance |